Cited by

• A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015.

  Hollingworth W, Jones T, Reeves BC, Peto T. Hollingworth W, et al. BMJ Open. 2017 Oct 22;7(10):e018289. doi: 10.1136/bmjopen-2017-018289. BMJ Open. 2017. PMID: 29061629 Free PMC article.
• National Institute for Health and Care Excellence, social values and healthcare priority setting.

  Littlejohns P, Chalkidou K, Culyer AJ, Weale A, Rid A, Kieslich K, Coultas C, Max C, Manthorpe J, Rumbold B, Charlton V, Roberts H, Faden R, Wilson J, Krubiner C, Mitchell P, Wester G, Whitty JA, Knight S. Littlejohns P, et al. J R Soc Med. 2019 May;112(5):173-179. doi: 10.1177/0141076819842846. Epub 2019 Apr 2. J R Soc Med. 2019. PMID: 30939251 Free PMC article. No abstract available.
• Minimizing Risks Is Not Enough: The Relevance of Benefits to Protecting Research Participants.

  Wendler D. Wendler D. Perspect Biol Med. 2020;63(2):346-358. doi: 10.1353/pbm.2020.0023. Perspect Biol Med. 2020. PMID: 33416657 Free PMC article.
• Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations.

  Franklin M, Lomas J, Richardson G. Franklin M, et al. Pharmacoeconomics. 2020 Jul;38(7):665-681. doi: 10.1007/s40273-020-00907-5. Pharmacoeconomics. 2020. PMID: 32291596 Free PMC article. Review.
• The complexities of integrating evidence-based preventative health into England's NHS: lessons learnt from the case of PrEP.

  Khan T, Coultas C, Kieslich K, Littlejohns P. Khan T, et al. Health Res Policy Syst. 2023 Jun 14;21(1):53. doi: 10.1186/s12961-023-00998-4. Health Res Policy Syst. 2023. PMID: 37316881 Free PMC article.